Indianapolis, IN, United States of America

Mythili Koneru

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Curevac Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mythili Koneru. Retrieved from https://idiyas.com/inventor/mythili-koneru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mythili Koneru: Innovator in mRNA Technology

Introduction

Mythili Koneru is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of mRNA technology, particularly with her innovative work on KRAS variant mRNA molecules. Her research is pivotal in advancing therapeutic approaches for various diseases.

Latest Patents

Mythili holds a patent for KRAS variant mRNA molecules, showcasing her expertise and commitment to innovation. This patent represents a crucial step in the development of targeted therapies that can potentially improve patient outcomes.

Career Highlights

Mythili is currently employed at CureVac AG, a company known for its groundbreaking work in mRNA technology. Her role at CureVac AG allows her to collaborate with leading experts in the field and contribute to cutting-edge research.

Collaborations

Mythili has worked alongside talented colleagues, including Katja Fiedler and Amit Aggarwal. These collaborations enhance the research environment and foster innovation within the team.

Conclusion

Mythili Koneru is a trailblazer in the field of mRNA technology, with her patent and work at CureVac AG highlighting her contributions to medical science. Her dedication to innovation continues to inspire advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…